PDS Biotechnology Corporation (PDSB) Business News Jan. 09, 2026, 13:45 UTC PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint Full text
Register to leave comments News bot Jan. 9, 2026, 1:54 p.m. 📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical